Molecular Genetics and Genomics. New research from the labs of Milan Chheda and Michael Diamond at Washington University and Jeremy Rich at UC San Diego shows that the virus kills brain cancer stem cells, the kind of cells most resistant to standard treatments. The Washington University SPORE, led by Dan Link is one of only three academic centers in the U.S. to receive this grant. SHARE. Altogether, they identified about 300 genes that drive tumor growth. Human and Statistical Genetics. . Our division has a strong presence in clinical, translational, and basic research. Contact Advancing science through biostatistics and education The Division of Biostatistics is a medical school-wide facility that engages in research, biostatistical consultation, teaching and training. WU Record 1/9/19, Their gift establishes the Paula C. and Rodger O. Riney Blood Cancer Research Initiative Fund to develop promising new treatments for multiple myeloma. WashU is a world-class research university with our roots firmly in St. Louis. We have a diverse research base with a number of faculty conducting basic and clinical investigation into a wide range of digestive disorders. St. Louis, MO 63110. Life at WashU > Our Students Class of 2026 Profile Our selection process is guided by a diverse committee of admissions professionals in an effort to ensure that, together, our five academic divisions create a community that is welcoming, nurturing, and intellectually rigorous. WU Record 9/16/19 | PNAS 2019 Sep 16, Washington University has received a $5 million grant to establish the Edward P. Evans Myelodysplastic Syndromes Center led by oncologistMatthew Walter. See Diversity Efforts Featured Stories WU Record 3/7/22 | Gastroenterology 2022 Mar 7, Glioblastoma, an aggressive cancer in the brain or spinal cord, has proven stubbornly resistant to radiation, chemotherapy, and newer immunotherapies, with fewer than 10% of patients surviving longer than five years after diagnosis. The researchers demonstrated that some protein alterations can be used to identify drugs that may work against some cancers. They showed how blocking the downstream effects of these mutations can lead to normal production of blood cells. Division of Bone and Mineral Diseases | Washington University in St. Louis JOHN T. MILLIKEN DEPARTMENT OF INTERNAL MEDICINE Division of Bone and Mineral Diseases About Us Patient Care Education Research News Events More Contact Giving The home for bone health Education: 314-454-7376. POSTED. Its purpose is to help doctors match cancer mutations found in patients tumors with drugs that target such genetic errors. St. Louis, MO 63110-1093. Nat Struct Mol Biol 2022 Mar 24, Stuart A. Kornfeld, MD, the David C. and Betty Farrell Distinguished Professor of Medicine at Washington University School of Medicine, has received the 2022 Roscoe O. Brady Award for Innovation and Accomplishment from the WORLDSymposium (WORLD is an acronym for Were Organizing Research on Lysosomal Diseases), a research conference dedicated to lysosomal diseases. St. Louis, MO 63130-4899. Submissions are curated by editors and moderators who are experts in the field. Stem Cell Reports 2017 Aug 8 | WU Record 7/27/17, Studying mice with breast tumors transplanted from patients, a group at Washington University led by Li Ding, in collaboration with colleagues at The Broad Institute of MIT and Harvard and Baylor College of Medicine, have analyzed the proteins present in these tumors. WU Record 7/30/19, In collaboration with investigators at Rush University in Chicago, David DeNardo and colleagues have found a chemical compound that promotes a vigorous immune assault against pancreatic cancer in mice. Immunology. COVID-19 Resources; Canvas; To schedule a virtual visit please call 314-362-8200 or request an appointment online. The Parents & Families website has been specifically designed with your questions in mind; however, if you are not finding what you are looking for, please call 844-935-5040. To learn more, please visit Washington University Physicians. Many of our dermatologists are also named Best Doctors in America . We want you to engage with your peers and with your university, to create an experience where you can learn and grow. This program includes genetic counseling and screening of family members with a history of prostate cancer. To schedule a virtual visit please call 314-362-8200 or request an appointment online . Division of Gastroenterology Education General Gastroenterology Fellowship Advanced IBD Fellowships Advanced Endoscopy Fellowship Program Past Fellows Patient Care National leaders in digestive and liver diseases For over 50 years, the division has been involved in the treatment, research and training of diseases of the digestive tract. For North American referrals, physicians may call the Barnes-Jewish Hospital Doctors Access Line at (800) 252-DOCS (3627). Nature Genetics 2016 Jun 13 | WU Record 6/13/16, Tim Ley is being recognized for his pioneering research in cancer genomics. Ureteropelvic Junction (UPJ) Obstruction in Children, Surgery for Prostate Cancer: Laparoscopic, Advanced Optical Imaging Cancer Detection, Laparoscopic Retroperitoneal Lymph Node Dissection (RPLND), Planning Center for Research in Benign Urology, Urologic Trauma and Reconstruction Fellowship, Communicate securely with your physicians office, Informed Consent for Telehealth Consultation. Use this page as a starting guide for exploring St. Louis. Please visit our website at https://hr.wustl.edu/benefits/ to view a summary of benefits. Washington University (Missouri) sports news and features, including conference, nickname, location and official social media handles. Email studentaffairs@wustl.edu. Now, a team led by Todd Fehniger has shown in preclinical studies conducted in mice and human cells that this type of cell-based immunotherapy also could be effective against solid tumors, starting with melanoma, a type of skin cancer that can be deadly if not caught early. WU Record 5/10/18, An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants, new research from Jaebok Choi, John DiPersio and colleagues. At WashU, we strive to provide a best-in-class student experience. The Washington University Division of Reproductive Endocrinology and Infertility has been a leader in assisted reproductive technologies (ART) from the start. Here you'll find an array of resources and opportunities that support our meaningful commitment to diversity, equity and inclusion. As a pioneer in developing treatments for heart and lung disease in adults and children, the Division of Cardiothoracic Surgery provides leading-edge medical and critical care , research and training . It has a total undergraduate enrollment of 8,034 (fall 2021), its setting is city, and the campus size is 169 . How much does Washington University in St. Louis in the United States pay? WU Record 7/3/19 | Science Translational Medicine 2019 Jul 3, Tim Ley led the team that first sequenced a cancer genome, identifying mutations in DNA that lead to cancer growth. For more information select a division below. Washington University Division of Urology Now Offering Virtual Visits Washington University Urology is committed to helping you manage your health and is now offering virtual patient visits. These studies helped to create a foundation for the Cancer Genome Atlas, elucidated many previously unknown drivers of AML, and defined the role of clonal heterogeneity in AML progression and relapse. That grant enabled him to set out on a field of study that would lay the foundation for understanding cells' behavior in health and inherited diseases. . WU Record 9/11/19, A team of Washington University investigators led by Tim Ley have been awarded a $15 million NIH grant to better understand the genetic changes that drive acute myeloid leukemia and predict patients responses to therapy. 1985: First baby in Missouri conceived . Lee. Profiles Laboratories Clinical trials staff Faculty & Staff Please note that all salary figures are approximations based upon third party submissions to Indeed. WU Record 7/10/20, Matthew J. Walter, MD, has been named the inaugural Edward P. Evans Endowed Professor at Washington University School of Medicine. The facility will provide a central home for nearly all aspects of advanced cancer care for outpatients, improving the experience and comfort for patients and their families. John T. Milliken Department of Internal Medicine. Janet S. Lee, MD, a highly regarded physician-scientist in pulmonary and critical care medicine, has been chosen to lead the Division of Pulmonary & Critical Care Medicine in the Department of Medicine at Washington University School of Medicine in St. Louis. View contacts WU Record 5/5/21, The Zika virus that ravaged the Americas, leaving many babies with permanent brain damage, may have a silver lining, according to a study published by Milan Chheda and colleagues. WU Record 6/29/21 | Clin Cancer Res 2021 Jun 29, The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation in the KRAS gene, according to results of a global phase 2 clinical trial. WU Record 8/31/21 | Article 1 | Article 2, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is planning a new, nine-story facility on the Washington University Medical Campus dedicated solely to outpatient cancer care. The findings may enable development of more effective therapies tailored to patients, based on the genetic characteristics of their cancer cells. This evaluation resulted in a nearly perfect score, earning Siteman the highest possible rating exceptional by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). Our fellows have the opportunity . The Division of Rheumatology comprises twenty-five full-time and part-time faculty and staff members who contribute to the clinical care, research and educational mission at Washington University School of Medicine in St. Louis. Washington University School of Medicine. 314-454-6300. academicpediatrics@wustl.edu Twitter; RESOURCES. Nature Communications 2017 Mar 28 | WU Record 3/28/17, A group led by Obi and Malachi Griffith has developed an online "knowledgebase" to gather and organize information on cancer genomics, providing an educational forum for dissemination of information and discussion of the clinical significance of cancer genome alterations. The study, led by David DeNardo and Li Ding also provides insights into treatment resistance and how immunotherapy could be harnessed to treat this aggressive tumor type. CIS Search Division of Pediatric Critical Care Medicine. Genome sequencing and protein analysis of the tumors will be performed to seek clues to how some of them develop drug resistance. Washington University in St. Louis School of Medicine's Division of Biostatistics offers the Master of Science in Biostatistics (MSIBS) degree program. Division of Geriatrics & Nutritional Sciences | Washington University in St. Louis National leaders in nutrition, metabolism, obesity and aging research We perform cutting-edge basic and clinical research and we train future leaders in the fields of geriatrics and nutritional science. WU Record 6/28/22, Advances in cellular immunotherapy that spur genetically modified T cells (CAR-T cells) to attack cancer cells have revolutionized the treatment of certain blood cancers. The knowledge could help guide treatment decisions. Among the medical conditions treated by this practice and treatment options it offers are the following: Kidney stone diseaseProstate cancerBenign prostate diseaseBladder cancerTesticular cancerKidney cancerFemale urinary incontinenceMale sexual dysfunctionMale infertilityPediatric urologic surgeryReconstructive surgery. WU Record 10/9/20 | Cell 2020 Oct 2, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis has been recognized once again as a top U.S. cancer institution, based on a review of its research programs. WU Record 10/31/18, A large genomic analysis led by Obi Griffith in the Division of Oncology and The McDonnell Genome Institute has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer. Mailing Address. Connecting investigators from multiple disciplines who collaborate on innovative projects that affect public health and clinical care. Our specialties Food allergies Asthma Drug allergies Skin allergies Seasonal/ Washington University Urology is committed to helping you manage your health and is now offering virtual patient visits. Benefits eligibility is subject to employment status, full-time equivalent (FTE) workload, and weekly standard hours. Living in St Louis. The division was previously led by John Atkinson, MD (1976-1992 and 2008-2017), Wayne Yokoyama, MD (1995-2007), and . Leukemia 2018 Apr 2 | WU Record 4/24/18, Researchers nationwide have reached a major milestone in describing the genetic landscape of cancer. Department of Otolaryngology. Clinical: 314-747-5361. WU Record 11/6/17, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Molecular Microbiology and Microbial Pathogenesis. 660 South Euclid Avenue. The strategy, developed in mouse studies, lets chemotherapy penetrate the protective environment of bone and minimizes toxic side effects. For over 50 years, the division has been involved in the treatment, research and training of diseases of the digestive tract. All divisions offer post-graduate training . Computational and Systems Biology. Such information may lead to new ways to prevent or treat breast cancer in African-American women. Division of Rheumatology | Washington University in St. Louis Division of Rheumatology Welcome to Rheumatology The Washington University School of Medicine, Division of Rheumatology applies a multidisciplinary approach to the understanding and advancement of research, education and medical care related to rheumatic diseases and conditions. St. Louis, MO 63110. Now, Patrick Grierson and Kian-Huat Lim have identified an anti-inflammatory drug, ATI-450, that makes pancreatic cancer cells more vulnerable to chemotherapy. Washington University in St. Louis was founded in 1853 as a nondenominational community of scholars, and has developed into an independent university known for its excellence in teaching and research and for the quality of its faculty and student body. WU Record 10/15/19, Mark Sands and his colleagues have discovered the precise biochemical pathway leading to Krabbe disease, a fatal genetic disorder in children that results in seizures, developmental regression and death, usually around age 3. EEO/AA . 314-454-2527 | Fax: 314-747-8880. WU Record 7/29/16, David DeNardo, Andrea Wang-Gillam and their colleagues have shown that immunotherapy against pancreatic cancer can be effective when given in conjunction with focal adhesion kinase (FAK) inhibitors, drugs that break up the fibrous tissue in these tumors. Twitter; Resources. Division of Maternal-Fetal Medicine & Ultrasound | Obstetrics & Gynecology | Washington University in St. Louis Division of Maternal-Fetal Medicine & Ultrasound Chief: Anthony Odibo, MD, MSCE The Division of Maternal Fetal Medicine and Ultrasound provides comprehensive assessment, care and consultation to pregnant women and their physicians. The official athletics website for the Washington University in St. Louis A grant from the National Cancer Institute will support anew research center led by Washington University (Ramaswamy Govindan, PI) and collaborators at the Broad Institute of MIT and Harvard. LEARN ABOUT THE DIVISION. Learn more Dermatologic & Cosmetic Surgery The dermatologic surgeons at Washington University provide comprehensive surgical procedures, as well as a range of cosmetic services. Patients in the Continental United States may refer to Family and Guest Services for assistance with lodging. Responsibilities include leadership, strategy, and day-to-day oversight of the Division, ensuring alignment with the goals and objectives of the . A phase 1 clinical trial to test the safety of FAK inhibitors in patients with advanced pancreatic cancer is underway. Four years ago, Lynn was diagnosed with dementia but decided against having a spinal tap that would have shown whether the cause was Alzheimer's disease. Experience the research, scholarship and creativity that drive us every day. Email. Employee Self Service ASH has invested $19 million to launch 10 new hematology-focused fellowship tracks at nine academic institutions across the country. Patients may benefit when indels are found in genes that already have drugs designed to counter the effects of mutation. Division surgeons are leaders in offering function-preserving surgical techniques that preserve erection among men with prostate cancer, ejaculation among men with testes cancer, and bladder function among all patients with bladder cancer. All first-year students come into WashU . WU Record 8/22/22 | Nat Genet 2022 Aug 22, The American Society of Hematology (ASH) announced the institutions that have been selected for the ASH Hematology-Focused Fellowship Training Program (HFFTP), an innovative initiative to address the critical need to expand the hematology workforce. WU Record 1/17/20, Washington University has received a $3.7 million grant from the National Institutes of Health to support an open-source database aimed at boosting personalized approaches to cancer treatment. WU Record 10/20/21, Foluso Ademuyiwa and her colleagues have surveyed oncologists to identify differences in physician attitudes that may contribute to a gap in referrals to genetic counseling and testing between Black women and white women with breast cancer. We are a community where you can be an individual and achieve exceptional things. 314-935-4526. Remarkably, just over half of all tumors analyzed carry genetic mutations that could be targeted by therapies already approved for use in patients. Department of Medicine Announcement. Kornfeld's research has been instrumental in understanding the workings of lysosomal proteins, which must make their way to the cells' lysosomes in order to digest cellular parts and molecules that are no longer needed and help cells dispose of viruses and bacteria. At the successful completion of the fellowship program, residents will have a broad exposure to all aspects of cardiothoracic surgery. Dr. Paul comes to us from the George Washington University . Glatz to lead pediatric cardiology division. Li Ding, assistant director of The McDonnell Genome Institute at Washington University, and scientists from about 20 other institutions have completed the genetic analyses of more than 11,000 tumors from patients, spanning 33 types of cancer - all part of The Cancer Genome Atlas (TCGA) project. Washington University has ongoing commitments to the initiatives that will continue to shape our ever changing world: We want to consider the issues around the cultural impact of the science that were doing. The multicenter study was led by co-senior author Chris Maher of the Oncology Division and investigators at the University of California, San Francisco. Studying human cancer cells and mice, Brian Van Tine and associates found that a two-drug combination targeting a tumors energy sources could be as effective and less toxic than methotrexate to treat osteosarcoma. WU Record 1/14/22 | Clin Cancer Res 2022 Jan 14, An aggressive chemotherapy regimen is the first-line treatment for pancreatic cancer, but the side effects can be severe, and many tumors stop responding to treatment. WU Record 10/18/21 | J Clin Oncol 2021 Oct 18, About 78-92% of lung cancers in patients who have never smoked can be treated with precision drugs already approved by the Food and Drug Administration to target specific mutations in a patients tumor. Facebook; Twitter; Resources. 660 S. Euclid Ave. Campus Box 8116. by Julia Evangelou Strait October 25, 2021. The division develops and adopts innovative approaches to engineering education and support the school's departments and their educational initiatives. Both studies appear in the August 31 issue of PLOS Medicine, which is a special issue of the journal dedicated to liquid biopsies. December 1, 2022. Dr. Link is the Alan A. and Edith L. Wolff Distinguished Professor of Medicine and Professor of Pathology and Immunology at Washington University School of Medicine. One of the tenets of Washington University School of Medicine is leading the way in innovative research. Developmental, Regenerative and Stem Cell Biology. Nature Genetics 2017 Jan 31 | WU Record 1/30/17, Many sarcomas lack an enzyme required for production of arginine, an essential component of most proteins, but attempts to kill the tumor cells by starving them of this nutrient have been unsuccessful. About the division: Danforth University Center, Suite 200; studentaffairs@wustl.edu; 314-935-4526; Hours: Mon-Fri 8:30 a.m.-5 p.m. . 660 S. Euclid Ave. Campus Box 8116. The drug is designed to shut down the effects of the mutation, which is found in about 13% of patients with lung adenocarcinoma, a common type of non-small-cell lung cancer. Division of Endocrinology, Metabolism & Lipid Research . A second project will focus on how pancreatic cancer spreads, or metastasizes, and develops resistance to standard treatments. He is best known for the study of how sugars attach to proteins and the roles these molecules play in how cells function. These leading-edge treatments have contributed to the divisions consistent ranking by U.S. News & World Report among the top urologic surgery centers in the United States. WU Record 3/5/18, While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer. WU Record 4/5/18, Stuart Kornfeld was honored on April 5 at a dinner at the Missouri Botanical Garden in recognition of his outstanding scientific contributions. The worlds first removal of a patients kidney through laparoscopic surgery was performed at Washington University School of Medicine in 1990. For patient appointments, call 314-362-8200. The division utilizes 27,039 square feet for its research, clinical, and education mission. WU Record 5/31/22 | Clin Cancer Res 2022 Apr 14, Cells synthesize 60 to 70 lysosomal hydrolases that must be delivered to the lysosome to allow proper functioning of this organelle. The Division of Nephrology at Washington University School of Medicine is at the cutting edge of research on cystic diseases affecting the kidney at both the basic science level and in clinical applications by translating these discoveries to patient care. This division serves as your home base. St. Louis, MO 63110-1093. Washington University School of Medicine. WU Record 6/13/22 | Nat Commun 2022 Jun 13, Synovial sarcoma is rare, with 900 to 1,000 new cases diagnosed annually, and is most typically diagnosed during adolescence and into young and middle adulthood. John T. Milliken Department of Medicine. People | Division of Urologic Surgery | Washington University in St. Louis People Urologists in the Division of Urologic Surgery are part of the Washington University Physicians medical group, which is recognized as an international leader in providing innovative, high-quality medical care. Washington University in St. Louis Request Information | Post an Event | Make a Donation The Division of Biology & Biomedical Sciences This 18-month, 42 credit hour program is designed to train students as critical thinkers and analysts in the discipline of biostatistics. A small clinical trial conducted by Rizwan Romee and Todd Fehniger provides evidence that the immune systems "natural killer" cells can be dialed up in the laboratory, trained to recall that activation and then effectively unleashed to destroy cancer cells in some patients. John T. Milken Department of Medicine Division of Endocrinology, Metabolism and Lipid Research | Washington University School of Medicine in St. Louis Division of Endocrinology, Metabolism & Lipid Research National leaders in the treatment of endocrine and metabolic disorders such as thyroid diseases, diabetes, hyperlipidemia and osteoporosis. Brian Van Tine and his colleagues have developed a way to attack this tumor using an investigational drug that triggers cell death. Phone: 314-935-4526. The grant will fund a clinical trial of the HER2 inhibitor neratinib in combination with fulvestrant in patients with metastatic breast tumors that have HER2 mutations and are estrogen-receptor positive. November 17, 2022 ST. LOUIS Joe knew something was terribly wrong when his wife, an energetic nurse and mother of three, became forgetful in her early 60s. European Urology 2016 Jul 22 | WU Record 8/2/16, Foluso Ademuyiwa and her colleague Laura Beirut (Department of Psychiatry) are launching a major study in African-American women with breast cancer to learn whether their genetic risks are influenced by the same mutations that affect white women or are altogether different mutations. Washington University School of Medicine in St. Louis offers outstanding fellowship training in infectious diseases, combining rigorous clinical and research opportunities for the motivated learner seeking to grow in an innovative environment. The Division of Biostatistics is a medical school-wide facility that engages in research, biostatistical consultation, teaching and training. The information may expand the number of cancer patients who can benefit from existing drugs. The drug was developed by Washington University researchers who are planning a phase 1 clinical trial to investigate its safety and effectiveness in patients who have synovial sarcoma that has spread beyond the original tumor site. Explore our Programs Find a Consultant Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Dong J, Adhikary S, Zhou L, Schuberth PC, Faghmous I, Masouleh BK, Houot R J Hematol Oncol 2022 Dec 10;15(1):170, Montoya LM, Kosorok MR, Geng EH, Schwab J, Odeny TA, Petersen ML Biometrics 2022 Dec 9; [ahead of print], Meroni A, Grosser J, Agashe S, Ramakrishnan N, Jackson J, Verma P, Baranello L, Vindigni A Sci Adv 2022 Dec 9;8(49):eabq0648, Covut F, Sanfilippo KM Hematology Am Soc Hematol Educ Program 2022 Dec 9;2022(1):363-367, Tian R, Wiley B, Liu J, Zong X, Truong B, Zhao S, Uddin MM, Niroula A, Miller CA, Mukherjee S, Heiden BT, Luo J, Puri V, Kozower BD, Walter MJ, Ding L, Link DC, Amos CI, Ebert BL, Govindan R, Natarajan P, Bolton KL, Cao Y J Clin Oncol 2022 Dec 8:JCO2200857; [ahead of print], Kim S, Lim S, Kim B, Ritchey J, Vij K, Prior J, Marsala L, Stoner A, Gao F, Achilefu S, Cooper ML, DiPersio JF, Choi J Blood 2022 Dec 7:blood2021012687; [ahead of print], Barlin M, Erdmann-Gilmore P, Mudd JL, Zhang Q, Seymour RW, Guo Z, Miessner JR, Goedegebuure SP, Bi Y, Osorio OA, Alexander-Brett J, Li S, Ma CX, Fields RC, Townsend RR, Held JM Mol Cell Proteomics 2022 Dec 2:100476; [ahead of print], Tepper SC, Holten AK, Jeffe DB, England PH, Hong ZL, Perez M, Ghert M, Hirbe AC, Cipriano CA Surg Oncol 2022 Dec;45:101861, Al-Kadhimi Z, Callahan M, Fehniger T, Cole KE, Vose J, Hinrichs S Int Immunopharmacol 2022 Dec;113(Pt A):109387, Kitko CL, Arora M, DeFilipp Z, Zaid MA, Di Stasi A, Radojcic V, Betts CB, Coussens LM, Meyers ML, Qamoos H, Ordentlich P, Kumar V, Quaranto C, Schmitt A, Gu Y, Blazar BR, Wang TP, Salhotra A, Pusic I, Jagasia M, Lee SJ J Clin Oncol 2022 Dec 2:JCO2200958; [ahead of print], Berchuck JE, Facchinetti F, DiToro DF, Baiev I, Majeed U, Reyes S, Chen C, Zhang K, Sharman R, Uson Junior PLS, Maurer J, Shroff RT, Pritchard CC, Wu MJ, Catenacci DVT, Javle M, Friboulet L, Hollebecque A, Bardeesy N, Zhu AX, Lennerz JK, Tan B, Borad M, Parikh AR, Kiedrowski LA, Kelley RK, Mody K, Juric D, Goyal L Ann Oncol 2022 Dec;33(12):1269-1283, SanMiguel JM, Eudy E, Loberg MA, Young KA, Mistry JJ, Mujica KD, Schwartz LS, Stearns TM, Challen GA, Trowbridge JJ Cancer Discov 2022 Dec 2;12(12):2763-2773, Lander VE, Belle JI, Kingston NL, Herndon JM, Hogg GD, Liu X, Kang LI, Knolhoff BL, Bogner SJ, Baer JM, Zuo C, Borcherding NC, Lander DP, Mpoy C, Scott J, Zahner M, Rogers BE, Schwarz JK, Kim H, DeNardo DG Cancer Discov 2022 Dec 2;12(12):2774-2799, Slade M, Martin TG, Nathwani N, Fiala MA, Rettig MP, Gao F, Deol A, Buadi FK, Kaufman JL, Hofmeister CC, Gregory TK, Berdeja J, Chari A, Rosko A, Vij R Leukemia 2022 Dec;36(12):2917-2921, Goldsmith SR, Streeter S, Covut F Curr Hematol Malig Rep 2022 Dec;17(6):286-297, De Togni E, Wan F, Slade M, Plach K, Abboud R Leuk Lymphoma 2022 Dec;63(12):2975-2981, Lavasidis G, Markozannes G, Voorhies K, Trikalinos NA, Petridou ET, Panagiotou OA, Ntzani EE Crit Rev Oncol Hematol 2022 Dec;180:103845, McHenry S, Zong X, Shi M, Fritz CDL, Pedersen KS, Peterson LR, Lee JK, Fields RC, Davidson NO, Cao Y Hepatol Commun 2022 Dec;6(12):3299-3310, Dehdashti F, Reimers MA, Shoghi KI, Chen DL, Luo J, Rogers B, Pachynski RK, Sreekumar S, Weimholt C, Zhou D Mol Imaging Biol 2022 Dec;24(6):853-861, Patel DA, Kahl BS Cancer 2022 Dec 1;128(23):4047-4051, Wang TF, Sanfilippo KM, Douketis J, Falanga A, Karageorgiou J, Maraveyas A, Ortel TL, Soff G, Vedantham S, Zwicker JI J Thromb Haemost 2022 Dec;20(12):3026-3038, Ji JX, Cochrane DR, Negri GL, Colborne S, Spencer Miko SE, Hoang LN, Farnell D, Tessier-Cloutier B, Huvila J, Thompson E, Leung S, Chiu D, Chow C, Ta M, Kobel M, Feil L, Anglesio M, Goode EL, Bolton K, Morin GB, Huntsman DG J Pathol 2022 Dec;258(4):325-338, Trikalinos NA, Hammill C, Liu J, Navale P, Winter K, Chatterjee D, Iravani A, Amin M, Itani M Abdom Radiol (NY) 2022 Dec;47(12):4096-4102, Yano M, Shetty AS, Williams GA, Lancia S, Trikalinos NA, Hammill CW, Hawkins WG, Salter A, Chatterjee D Abdom Radiol (NY) 2022 Dec;47(12):3971-3985, Khaddour K, Zhou A, Butt OH, Budde G, Malashevich AK, Ansstas G Front Oncol 2022 Nov 17;12:978996, Heiden BT, Eaton DB, Chang SH, Yan Y, Schoen MW, Thomas TS, Patel MR, Kreisel D, Nava RG, Meyers BF, Kozower BD, Puri V J Natl Cancer Inst 2022 Nov 29:djac208; [ahead of print], Grierson PM, Tan B, Pedersen KS, Park H, Suresh R, Amin MA, Trikalinos NA, Knoerzer D, Kreider B, Reddy A, Liu J, Der CJ, Wang-Gillam A, Lim KH Oncologist 2022 Nov 25:oyac237; [ahead of print], Duncavage EJ, Bagg A, Hasserjian RP, DiNardo CD, Godley LA, Iacobucci I, Jaiswal S, Malcovati L, Vannucchi AM, Patel KP, Arber DA, Arcila ME, Bejar R, Berliner N, Borowitz MJ, Branford S, Brown AL, Cargo CA, Dohner H, Falini B, Garcia-Manero G, Haferlach T, Hellstrom-Lindberg E, Kim AS, Klco JM, Komrokji R, Lee-Cheun Loh M, Loghavi S, Mullighan CG, Ogawa S, Orazi A, Papaemmanuil E, Reiter A, Ross DM, Savona M, Shimamura A, Skoda RC, Sole F, Stone RM, Tefferi A, Walter MJ, Wu D, Ebert BL, Cazzola M Blood 2022 Nov 24;140(21):2228-2247, Berrien-Elliott MM, Jacobs MT, Fehniger TA Blood 2022 Nov 23:blood2022016200; [ahead of print], Ince S, Itani M, Henke LE, Smith RK, Wise PE, Mutch MG, Glasgow SC, Silviera ML, Pedersen KS, Hunt SR, Kim H, Fraum TJ Tomography 2022 Nov 9;8(6):2723-2734, Clifton K, Gao F, Jabbari J, Van Aman M, Dulle P, Hanson J, Wildes TM J Geriatr Oncol 2022 Nov;13(8):1122-1131, Noel MS, Kim S, Hartley ML, Wong S, Picozzi VJ, Staszewski H, Kim DW, Van Tornout JM, Philip PA, Chung V, Ocean AJ, Wang-Gillam A Cancer Med 2022 Nov;11(22):4169-4181, Bowman-Kirigin JA, Desai R, Saunders BT, Wang AZ, Schaettler MO, Liu CJ, Livingstone AJ, Kobayashi DK, Durai V, Kretzer NM, Zipfel GJ, Leuthardt EC, Osbun JW, Chicoine MR, Kim AH, Murphy KM, Johanns TM, Zinselmeyer BH, Dunn GP Cancer Immunol Res 2022 Nov 21:CIR-22-0098; [ahead of print], Berrian J, Liu Y, Ezenwajiaku N, Moreno-Aspitia A, Holton SJ, Toriola AT, Colditz GA, Housten AJ, Hall L, Fiala MA, Ademuyiwa FO Cancer Med 2022 Nov 20; [ahead of print], Bardia A, Mayer I, Winer E, Linden HM, Ma CX, Parker BA, Bellet M, Arteaga CL, Cheeti S, Gates M, Chang CW, Fredrickson J, Spoerke JM, Moore HM, Giltnane J, Friedman LS, Chow Maneval E, Chan I, Jhaveri K Breast Cancer Res Treat 2022 Nov 19; [ahead of print], Rosenbaum E, Chugh R, Ryan CW, Agulnik M, Milhem MM, George S, Jones RL, Chmielowski B, Van Tine BA, Tawbi H, Elias AD, Read WL, Budd GT, Qin LX, Rodler ET, Hirman J, Weiden P, Bennett CM, Livingston PO, Ragupathi G, Hansen D, D'Angelo SP, Tap WD, Schwartz GK, Maki RG, Carvajal RD Eur J Cancer 2022 Nov;176:155-163, Butt OH, Zhou AY, Caimi PF, Luckett PH, Wisch JK, Derenoncourt P, Lee K, Wu GF, de Lima MJG, Campian JL, Frank MJ, DiPersio JF, Ghobadi A, Ances BM JAMA Oncol 2022 Nov 1;8(11):1652-1657, Ghobadi A, Slade M, Kantarjian H, Alvarenga J, Aldoss I, Mohammed KA, Jabbour E, Faramand R, Shah B, Locke F, Fingrut W, Park JH, Short NJ, Gao F, Uy GL, Westervelt P, DiPersio JF, Champlin RE, Al Malki MM, Ravandi F, Kebriaei P Blood 2022 Nov 17;140(20):2101-2112, Pemmaraju N, Kantarjian HM, Sweet KL, Wang ES, Senapati J, Wilson NR, Konopleva MY, Frankel AE, Gupta V, Mesa RA, Ulrickson ML, Gorak E, Bhatia S, Budak-Alpdogan T, Mason JR, Garcia-Romero MT, Lopez-Santiago NC, Cesarman-Maus G, Vachhani P, Lee S, Bhatt VR, Blum W, Walter RB, Bixby D, Gojo I, Duvic M, Rampal RK, de Lima M, Foran JM, Fathi AT, Hall A, Jacoby MA, Lancet JE, Mannis GN, Stein AS, Mims AS, Rizzieri D, Olin RL, Perl AE, Schiller GJ, Shami PJ, Stone RM, Strickland S, Wieduwilt MJ, Daver NG, Ravandi F, Vasu S, Guzman ML, Roboz GJ, Khoury JD, Qazilbash MH, Aung P, Cuglievan B, Madanat YF, Kharfan-Dabaja MA, Pawlowska AB, Taylor J, Tallman MS, Dhakal P, Lane AA Blood 2022 Nov 18:blood2022017865; [ahead of print], Kuruvilla J, Armand P, Hamadani M, Kline J, Moskowitz CH, Avigan D, Brody JD, Ribrag V, Herrera AF, Morschhauser F, Kanate A, Zinzani PL, Bitran J, Ghesquieres H, Schuster SJ, Farooqui M, Marinello P, Bartlett NL Leuk Lymphoma 2022 Nov 18:1-10; [ahead of print], Donahue K, Xie H, Li M, Gao A, Ma M, Wang Y, Tipton R, Semanik N, Primeau T, Li S, Li L, Tang W, Xu W J Biol Chem 2022 Nov 14:102700; [ahead of print], Liau LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, Tran DD, Ansstas G, Cobbs CS, Heth JA, Salacz ME, D'Andre S, Aiken RD, Moshel YA, Nam JY, Pillainayagam CP, Wagner SA, Walter KA, Chaudary R, Goldlust SA, Lee IY, Bota DA, Elinzano H, Grewal J, Lillehei K, Mikkelsen T, Walbert T, Abram S, Brenner AJ, Ewend MG, Khagi S, Lovick DS, Portnow J, Kim L, Loudon WG, Martinez NL, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Giglio P, Gligich O, Krex D, Lindhorst SM, Lutzky J, Meisel HJ, Nadji-Ohl M, Sanchin L, Sloan A, Taylor LP, Wu JK, Dunbar EM, Etame AB, Kesari S, Mathieu D, Piccioni DE, Baskin DS, Lacroix M, May SA, New PZ, Pluard TJ, Toms SA, Tse V, Peak S, Villano JL, Battiste JD, Mulholland PJ, Pearlman ML, Petrecca K, Schulder M, Prins RM, Boynton AL, Bosch ML JAMA Oncol 2022 Nov 17; [ahead of print], Salvador C, Mark P, Hoenemeyer T, McDonald V Complement Ther Clin Pract 2022 Nov;49:101639, Chen H, Gesumaria L, Park YK, Oliver TG, Singer DS, Ge K, Schrump DS Mol Cancer Res 2022 Nov 15:MCR-22-0594; [ahead of print], Sridaran D, Chouhan S, Mahajan K, Renganathan A, Weimholt C, Bhagwat S, Reimers M, Kim EH, Thakur MK, Saeed MA, Pachynski RK, Seeliger MA, Todd Miller W, Feng FY, Mahajan NP Nat Commun 2022 Nov 14;13(1):6929, Krysiak K, Danos AM, Saliba J, McMichael JF, Coffman AC, Kiwala S, Barnell EK, Sheta L, Grisdale CJ, Kujan L, Pema S, Lever J, Ridd S, Spies NC, Andric V, Chiorean A, Rieke DT, Clark KA, Reisle C, Venigalla AC, Evans M, Jani P, Takahashi H, Suda A, Horak P, Ritter DI, Zhou X, Ainscough BJ, Delong S, Kesserwan C, Lamping M, Shen H, Marr AR, Hoang MH, Singhal K, Khanfar M, Li BV, Lin WH, Terraf P, Corson LB, Salama Y, Campbell KM, Farncombe KM, Ji J, Zhao X, Xu X, Kanagal-Shamanna R, King I, Cotto KC, Skidmore ZL, Walker JR, Zhang J, Milosavljevic A, Patel RY, Giles RH, Kim RH, Schriml LM, Mardis ER, Jones SJM, Raca G, Rao S, Madhavan S, Wagner AH, Griffith M, Griffith OL Nucleic Acids Res 2022 Nov 14:gkac979; [ahead of print], Bolton KL, Chen D, Corona de la Fuente R, Fu Z, Murali R, Kobel M, Tazi Y, Cunningham JM, Chan ICC, Wiley BJ, Moukarzel LA, Winham SJ, Armasu SM, Lester J, Elishaev E, Laslavic A, Kennedy CJ, Piskorz A, Sekowska M, Brand AH, Chiew YE, Pharoah P, Elias KM, Drapkin R, Churchman M, Gourley C, DeFazio A, Karlan B, Brenton JD, Weigelt B, Anglesio MS, Huntsman D, Gayther S, Konner J, Modugno F, Lawrenson K, Goode EL, Papaemmanuil E Clin Cancer Res 2022 Nov 14;28(22):4947-4956, Zimmerman SM, Nixon SJ, Chen PY, Raj L, Smith SR, Paolini RL, Lin PN, Souroullas GP Oncogene 2022 Nov;41(46):4983-4993, Lee S, Ma C, Shi Q, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Lewis D, Tan B, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF, Meyerhardt JA J Clin Oncol 2022 Nov 11:JCO2201637; [ahead of print], Akkad N, Kodgule R, Duncavage EJ, Mehta-Shah N, Spencer DH, Watkins M, Shirai C, Myckatyn T Aesthet Surg J 2022 Nov 10:sjac282; [ahead of print], Davis AA, Gerratana L, Clifton K, Medford AJ, Velimirovic M, Hensing WL, Bucheit L, Shah AN, D'Amico P, Reduzzi C, Zhang Q, Dai CS, Denault EN, Bagegni NA, Opyrchal M, Ademuyiwa FO, Bose R, Gradishar WJ, Behdad A, Ma CX, Bardia A, Cristofanilli M EBioMedicine 2022 Nov 1;86:104316; [ahead of print], Goldsmith SR, Ghobadi A, DiPersio JF, Hill B, Shadman M, Jain T Transplant Cell Ther 2022 Nov;28(11):727-736, Cybulla E, Vindigni A Nat Rev Cancer 2022 Nov 2; [ahead of print], Cortese MJ, Wei W, Cerdena S, Watkins MP, Olson M, Jodon G, Kaiser J, Haverkos B, Hughes ME, Namoglu E, Grover NS, Snow A, Orellana-Noia V, Rainey M, Sohail M, Rudoni J, Portell C, Voorhees T, Landsburg DJ, Kamdar M, Kahl BS, Hill BT Leuk Lymphoma 2022 Nov 2:1-12; [ahead of print], Zhu C, Iwase M, Li Z, Wang F, Quinet A, Vindigni A, Shao J Nat Commun 2022 Nov 1;13(1):6531, Sjostrom M, Zhao SG, Levy S, Zhang M, Ning Y, Shrestha R, Lundberg A, Herberts C, Foye A, Aggarwal R, Hua JT, Li H, Bergamaschi A, Maurice-Dror C, Maheshwari A, Chen S, Ng SWS, Ye W, Petricca J, Fraser M, Chesner L, Perry MD, Moreno-Rodriguez T, Chen WS, Alumkal JJ, Chou J, Morgans AK, Beer TM, Thomas GV, Gleave M, Lloyd P, Phillips T, McCarthy E, Haffner MC, Zoubeidi A, Annala M, Reiter RE, Rettig MB, Witte ON, Fong L, Bose R, Huang FW, Luo J, Bjartell A, Lang JM, Mahajan NP, Lara PN, Evans CP, Tran PT, Posadas EM, He C, Cui XL, Huang J, Zwart W, Gilbert LA, Maher CA, Boutros PC, Chi KN, Ashworth A, Small EJ, He HH, Wyatt AW, Quigley DA, Feng FY Cancer Res 2022 Nov 2;82(21):3888-3902, Anurag M, Jaehnig EJ, Krug K, Lei JT, Bergstrom EJ, Kim BJ, Vashist TD, Huynh AMT, Dou Y, Gou X, Huang C, Shi Z, Wen B, Korchina V, Gibbs RA, Muzny DM, Doddapaneni H, Dobrolecki LE, Rodriguez H, Robles AI, Hiltke T, Lewis MT, Nangia JR, Nemati Shafaee M, Li S, Hagemann IS, Hoog J, Lim B, Osborne CK, Mani DR, Gillette MA, Zhang B, Echeverria GV, Miles G, Rimawi MF, Carr SA, Ademuyiwa FO, Satpathy S, Ellis MJ Cancer Discov 2022 Nov 2;12(11):2586-2605, Stephens DM, Li H, Constine LS, Fitzgerald TJ, Leonard JP, Kahl BS, Song JY, LeBlanc ML, Smith SM, Persky DO, Friedberg JW Haematologica 2022 Nov 1;107(11):2732-2736, Lim M, Weller M, Idbaih A, Steinbach J, Finocchiaro G, Raval RR, Ansstas G, Baehring J, Taylor JW, Honnorat J, Petrecca K, De Vos F, Wick A, Sumrall A, Sahebjam S, Mellinghoff IK, Kinoshita M, Roberts M, Slepetis R, Warad D, Leung D, Lee M, Reardon DA, Omuro A Neuro Oncol 2022 Nov 2;24(11):1935-1949, D'Souza A, Shah N, Rodriguez C, Voorhees PM, Weisel K, Bueno OF, Pothacamury RK, Freise KJ, Yue S, Ross JA, Polepally AR, Talati C, Lee S, Jin Z, Buelow B, Vij R, Kumar S J Clin Oncol 2022 Nov 1;40(31):3576-3586, Foley NC, Mehta-Shah N Curr Oncol Rep 2022 Nov;24(11):1489-1499, Herzog BH, Waqar SN, Devarakonda S, Ward JP, Gao F, Govindan R, Morgensztern D Lung Cancer 2022 Nov;173:101-106, Kantarjian HM, Jabbour E, Deininger M, Abruzzese E, Apperley J, Cortes J, Chuah C, DeAngelo DJ, DiPersio J, Hochhaus A, Lipton J, Nicolini FE, Pinilla-Ibarz J, Rea D, Rosti G, Rousselot P, Shah NP, Talpaz M, Srivastava S, Ren X, Mauro M Am J Hematol 2022 Nov;97(11):1419-1426, Hou YC, Neidich JA, Duncavage EJ, Spencer DH, Schroeder MC Hum Mutat 2022 Nov;43(11):1519-1530, Pemmaraju N, Harrison C, Gupta V, Verstovsek S, Scott B, Oh ST, Palandri F, Al-Ali HK, Sobas M, McMullin MF, Mesa R, Buckley S, Roman-Torres K, Vannucchi A, Yacoub A EJHaem 2022 Oct 20;3(4):1346-1351, Liu L, Dehner C, Grandhi N, Lyu Y, Borcherding DC, Chrisinger JSA, Zhang X, Luo J, Tao Y, Parkes A, Bui NQ, Davis EJ, Milhem MM, Monga V, Weiss M, Van Tine B, Hirbe AC Genes (Basel) 2022 Oct 24;13(11):1932, Sponagel J, Devarakonda S, Rubin JB, Luo J, Ippolito JE iScience 2022 Oct 12;25(11):105339, Camidge DR, Barlesi F, Goldman JW, Morgensztern D, Heist R, Vokes E, Spira A, Angevin E, Su WC, Hong DS, Strickler JH, Motwani M, Dunbar M, Parikh A, Noon E, Blot V, Wu J, Kelly K J Clin Oncol 2022 Oct 26:JCO2200739; [ahead of print], Brastianos PK, Twohy EL, Gerstner ER, Kaufmann TJ, Iafrate AJ, Lennerz J, Jeyapalan S, Piccioni DE, Monga V, Fadul CE, Schiff D, Taylor JW, Chowdhary SA, Bettegowda C, Ansstas G, De La Fuente M, Anderson MD, Shonka N, Damek D, Carrillo J, Kunschner-Ronan LJ, Chaudhary R, Jaeckle KA, Senecal FM, Kaley T, Morrison T, Thomas AA, Welch MR, Iwamoto F, Cachia D, Cohen AL, Vora S, Knopp M, Dunn IF, Kumthekar P, Sarkaria J, Geyer S, Carrero XW, Martinez-Lage M, Cahill DP, Brown PD, Giannini C, Santagata S, Barker FG 2nd, Galanis E J Clin Oncol 2022 Oct 26:JCO2102371; [ahead of print], Tesfazghi MT, Bass AR, Al-Hammadi N, Woller SC, Stevens SM, Eby CS, Scott MG, Snyder L, Wildes TS, Gage BF Cardiol Res Pract 2022 Oct 14;2022:8244047, Shim KG, Crain M, Augustin K, Oetjen KA Leuk Res Rep 2022 Oct 19;18:100353, Barnell EK, Fisk B, Skidmore ZL, Cotto KC, Basu A, Anand A, Richters MM, Luo J, Fronick C, Anurag M, Fulton R, Ellis MJ, Griffith OL, Griffith M, Ademuyiwa FO Sci Rep 2022 Oct 22;12(1):17732, Shree Bose (Authors include: Chheda MG) Cancer Cell 2022 Oct 18:S1535-6108(22)00475-5; [ahead of print], LaCasce AS, Dockter T, Ruppert AS, Kostakoglu L, Schoder H, Hsi E, Bogart J, Cheson B, Wagner-Johnston N, Abramson J, Blum K, Leonard JP, Bartlett NL J Clin Oncol 2022 Oct 21:JCO2200947; [ahead of print], Epperla N, Zhao Q, Mullick Chowdhury S, Shea L, Moyo T, Reddy N, Sheets JW, Weiner DM, Ramakrishnan Geethakumari P, Kandarpa M, Jordan Bruno X, Thomas C, Churnetski MC, Hsu A, Zurbriggen LD, Tan XC, Lindsey KG, Maakaron J, Caimi PF, Torka P, Bello C, Ayyappan S, Oh TS, Karmali R, Kim SH, Kress A, Kothari S, Sawalha Y, Christian B, David KA, Greenwell IB, Janakiram M, Kenkre VP, Olszewski AJ, Cohen JB, Palmisiano N, Umyarova ER, Wilcox RA, Awan FT, Alderuccio JP, Barta SK, Grover NS, Ghosh N, Bartlett NL, Herrera AF, Shouse G Blood Adv 2022 Oct 21:bloodadvances2022008634; [ahead of print], Li QK, Hu Y, Chen L, Schnaubelt M, Cui Zhou D, Li Y, Lu RJ, Thiagarajan M, Hostetter G, Newton CJ, Jewell SD, Omenn G, Robles AI, Mesri M, Bathe OF, Zhang B, Ding L, Hruban RH, Chan DW, Zhang H Clin Proteomics 2022 Oct 20;19(1):36, Ghobadi A, Landmann JH, Carter A, Cooper ML, Selli ME, Chang J, Baker M, Miller CA, Ferraro F, Chen DY, Smith AM, LaValle TA, Duncavage EJ, Chou J, Tam V, Benoun JM, Nater J, Scholler N, Milletti F, Vezan R, Bot A, Rossi JM, Singh N Blood Adv 2022 Oct 25;6(20):5634-5640, Nelvagal HR, Eaton SL, Wang SH, Eultgen EM, Takahashi K, Le SQ, Nesbitt R, Dearborn JT, Siano N, Puhl AC, Dickson PI, Thompson G, Murdoch F, Brennan PM, Gray M, Greenhalgh SN, Tennant P, Gregson R, Clutton E, Nixon J, Proudfoot C, Guido S, Lillico SG, Whitelaw CBA, Lu JY, Hofmann SL, Ekins S, Sands MS, Wishart TM, Cooper JD J Clin Invest 2022 Oct 17;132(20):e163107, Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, Spies NC, Ruzinova MB, Wang T, Abro B, Kreisel F, Parikh BA, Duncavage EJ, Frater JL, Lee YS, Hassan A, King J, Kohnen DR, Fiala MA, Welch JSS, Uy GL, Vij K, Vij R, Griffith M, Griffith OL, Wartman LD Blood Adv 2022 Oct 17:bloodadvances2022007496; [ahead of print], Li S, Bern MD, Miao B, Fan C, Xing X, Inoue T, Piersma SJ, Wang T, Colonna M, Kurosaki T, Yokoyama WM Elife 2022 Oct 3;11:e77294, LCMC study investigators (Authors include: Waqar SN) Nat Med 2022 Oct;28(10):2155-2161, Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Gunn A, Hecht JR, Hoffe S, Hubbard J, Hunt S, Jeck W, Johung KL, Kirilcuk N, Krishnamurthi S, Maratt JK, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stotsky-Himelfarb E, Tavakkoli A, Willett CG, Gregory K, Gurski L J Natl Compr Canc Netw 2022 Oct;20(10):1139-1167, Sanft T, Day A, Peterson L, Rodriguez MA, Ansbaugh S, Armenian S, Baker KS, Ballinger T, Broderick G, Demark-Wahnefried W, Dickinson K, Fairman NP, Friedman DL, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Neuman H, O'Connor T, Overholser L, Paskett ED, Patel C, Pirl W, Porpiglia A, Ruddy KJ, Schapira L, Shockney L, Smith S, Syrjala KL, Tevaarwerk A, Yang EH, Zee P, McMillian NR, Freedman-Cass DA J Natl Compr Canc Netw 2022 Oct;20(10):1080-1090, International Replication Repair Deficiency Consortium (Authors include: Peterson L) J Clin Oncol 2022 Oct 14:JCO2102873; [ahead of print], Wang-Gillam A, Lim KH, McWilliams R, Suresh R, Lockhart AC, Brown A, Breden M, Belle JI, Herndon J, Bogner SJ, Pedersen K, Tan B, Boice N, Acharya A, Abdiannia M, Gao F, Yoon HH, Zhu M, Trikalinos NA, Ratner L, Aranha O, Hawkins WG, Herzog BH, DeNardo DG Clin Cancer Res 2022 Oct 13:CCR-22-0308; [ahead of print], Kossenkov AV, Milcarek A, Notta F, Jang GH, Wilson JM, Gallinger S, Zhou DC, Ding L, Ghosh JC, Perego M, Morotti A, Locatelli M, Robert ME, Vaira V, Altieri DC PLoS One 2022 Oct 12;17(10):e0273520, Brotherton T, Burton S, Knoche E, Presti M ACG Case Rep J 2022 Oct 6;9(10):e00869, Yi J, Miller AT, Archambault AS, Jones AJ, Bradstreet TR, Bandla S, Hsu YS, Edelson BT, Zhou YW, Fremont DH, Egawa T, Singh N, Wu GF, Hsieh CS Sci Immunol 2022 Oct 14;7(76):eabo0777, Saliba RM, Alousi AM, Pidala J, Arora M, Spellman SR, Hemmer MT, Wang T, Abboud C, Ahmed S, Antin JH, Beitinjaneh A, Buchbinder D, Byrne M, Cahn JY, Choe H, Hanna R, Hematti P, Kamble RT, Kitko CL, Laughlin M, Lekakis L, MacMillan ML, Martino R, Mehta PA, Nishihori T, Patel SS, Perales MA, Rangarajan HG, Ringden O, Rosenthal J, Savani BN, Schultz KR, Seo S, Teshima T, van der Poel M, Verdonck LF, Weisdorf D, Wirk B, Yared JA, Schriber J, Champlin RE, Ciurea SO Transplant Cell Ther 2022 Oct;28(10):681-693, Li S, Yao JC, Oetjen KA, Krambs JR, Xia J, Zhang J, Schmidt AP, Helton NM, Fulton RS, Heath SE, Turnbull IR, Mbalaviele G, Ley TJ, Walter MJ, Link DC Blood 2022 Oct 6;140(14):1607-1620, Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Barta SK, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Cruz M, Dyer M, Farinha P, Gastier-Foster J, Gerrie AS, Grande B, Greiner TC, Griner N, Gross TG, Harris NL, Irvin JD, Jaffe ES, Henry D, Huppi RL, Leal FE, Lee M, Martin JP, Martin MR, Mbulaiteye SM, Mitsuyasu R, Morris V, Mullighan CG, Mungall AJ, Mungall K, Mutyaba I, Nokta M, Namirembe C, Noy A, Ogwang MD, Omoding A, Orem J, Ott G, Petrello H, Pittaluga S, Phelan JD, Ramos JC, Ratner L, Reynolds SJ, Rubinstein PG, Sissolak G, Slack GW, Soudi S, Swerdlow SH, Traverse-Glehen A, Wilson W, Wong JCH, Yarchoan R, ZenKlusen JC, Marra MA, Staudt LM, Scott DW, Morin RD Blood 2022 Oct 6:blood2022016534; [ahead of print], Heller G, Bradbury AM, Sands MS, Bongarzone ER Mol Ther 2022 Oct 3:S1525-0016(22)00606-2; [ahead of print], Wiley B, Parsons TM, Burkart S, Young AL, Erlandson KM, Tassiopoulos KK, Wu K, Gurnett C, Presti RM, Bolton KL, Challen GA Exp Hematol 2022 Oct;114:18-21, Nickless A, Zhang J, Othoum G, Webster J, Inkman MJ, Coonrod E, Fontes S, Rozycki EB, Maher CA, White NM Mol Cancer Res 2022 Oct 4;20(10):1481-1488, Jagadeesh D, Horwitz S, Bartlett NL, Kim Y, Jacobsen E, Duvic M, Little M, Trepicchio W, Fenton K, Onsum M, Lisano J, Advani R Oncologist 2022 Oct 1;27(10):864-873, Morschhauser F, Nastoupil L, Feugier P, Schiano de Colella JM, Tilly H, Palomba ML, Bachy E, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Le Gouill S, Daguindau N, Guidez S, Pica GM, Garcia-Sancho AM, Lopez-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, Andre M, Kalung W, Sehn LH, Izutsu K, Cartron G, Gkasiamis A, Crowe R, Xerri L, Fowler NH, Salles G J Clin Oncol 2022 Oct 1;40(28):3239-3245, Agarwal N, Tangen CM, Hussain MHA, Gupta S, Plets M, Lara PN, Harzstark AL, Twardowski PW, Paller CJ, Zylla D, Zibelman MR, Levine E, Roth BJ, Goldkorn A, Vaena DA, Kohli M, Crispino T, Vogelzang NJ, Thompson IM Jr, Quinn DI J Clin Oncol 2022 Oct 1;40(28):3301-3309, Mehta-Shah N Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S85-S86, Akkad N, Kodgule R, Duncavage E, Mehta-Shah N, Watkins M, Shirai C, Myckatyn T Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S402, Budde EL, Sehn LH, Matasar M, Schuster SJ, Assouline S, Giri P, Kuruvilla J, Canales M, Dietrich S, Fay K, Ku M, Nastoupil L, Wei MC, Yin S, Doral MY, Li CC, Huang H, Negricea R, Penuel E, O'Hear C, Bartlett NL Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S387, Orellana-Noia V, Reed D, McCook A, Sen J, Barlow C, Malecek MK, Watkins M, Kahl B, Spinner M, Advani R, Voorhees T, Snow A, Grover N, Ayers A, Romancik J, Liu Y, Huntington S, Chavez J, Saeed H, Lazaryan A, Raghunathan V, Spurgeon S, Ollila T, Prete CD, Olszewski A, Ayers E, Landsburg D, Echalier B, Lee J, Kamdar M, Calmi P, Fu T, Liu J, David K, Alharthy H, Law J, Karmali R, Shah H, Stephens D, Major A, Rojek A, Smith S, Yellala A, Kallam A, Nakhoda S, Khan N, Sohail M, Hill B, Barrett-Campbell O, Lansigan F, Switchenko J, Cohen J, Portell C Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S381, Flowers C, Tilly H, Morschhauser F, Sehn LH, Friedberg JW, Trneny M, Sharman JP, Herbaux C, Burke JM, Matasar M, Rai S, Izutsu K, Mehta-Shah N, Oberic L, Chauchet A, Jurczak W, Song Y, Greil R, Mykhalska L, Bergua-Burgues JM, Cheung MC, Pinto A, Shin HJ, Hapgood G, Munhoz E, Abrisqueta P, Gau JP, Hirata J, Jiang Y, Yan M, Lee C, Salles G Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S358-S359, Straus D, Radford J, Connors J, Kim WS, Gallamini A, Ramchandren R, Friedberg J, Advani R, Hutchings M, Evens A, Smolewski P, Savage K, Bartlett N, Eom HS, Abramson J, Dong C, Campana F, Fenton K, Puhlmann M, Ansell S Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S350, Carlo-Stella C, Ansell S, Zinzani PL, Radford J, Maddocks K, Pinto A, Collins GP, Bachanova V, Bartlett N, Bence-Bruckler I, Hamadani M, Kline J, Mayer J, Savage KJ, Advani R, Calmi P, Casasnovas RO, Feldman T, Hess B, Bastos-Oreiro M, Iyengar S, Eisen S, Negievich Y, Wang L, Wuerthner J, Herrera AF Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S347, Zavidij O, Haradhvala NJ, Meyer R, Cui J, Verstovsek S, Oh S, Mead A, Taverna P Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S331-S332, Oh S, Mesa R, Harrison C, Bose P, Gerds A, Gupta V, Swami A, Tyavanagimatt S, Buckley S, Roman-Torres K, Verstovsek S Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S327, Harrison C, Bose P, Mesa R, Gerds A, Oh S, Kiladijan JJ, Garcia-Gutierrez V, Vannucchi A, Scheid C, Sobas M, Verstovsek S, Buckley S, Roman-Torres K, Mascarenhas J Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326-S327, Gerds AT, Mesa R, Burke JM, Grunwald MR, Scherber R, Yu J, Hamer-Maansson JE, Oh ST Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326, Yacoub A, Borate U, Rampal R, Ali H, Wang E, Gerds A, Hobbs G, Kremyanskaya M, Winton E, O'Connell C, Goel S, Oh S, Schiller G, Assad A, Erickson-Viitanen S, Zhou F, Daver N Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S324, Apperley J, Kantarjian H, Deininger M, Abruzzese E, Cortes J, Chuah C, DeAngelo DJ, DiPersio J, Hochhaus A, Lipton JH, Nicolini F, Pinilla-Ibarz J, Rea D, Rosti G, Rousselot P, Mauro M, Shah N, Talpaz M, Vorog A, Ren X, Jabbour E Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S284-S285, Kahl BS, Giannopoulos K, Jurczak W, Simkovic M, Shadman M, Osterborg A, Laurenti L, Walker P, Opat S, Chan H, Ciepluch H, Greil R, Tani M, Trneny M, Brander DM, Flinn IW, Grosicki S, Verner E, Brown JR, Ghia P, Li J, Tian T, Zhou L, Marimpietri C, Paik JC, Cohen A, Robak T, Hillmen P, Tam CS Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S269-S270, Jacobs MT, Jain MD, Gao F, Nastoupil LJ, Spiegel JY, Lin Y, Dahiya S, Lunning M, Lekakis L, Reagan PM, Oluwole OO, McGuirk J, Deol A, Sehgal A, Goy A, Hill BT, Andreadis C, Munoz J, Chavez JC, Bennani NN, Rapoport AP, Vose JM, Miklos DB, Neelapu SS, Ghobadi A, Locke FL Clin Lymphoma Myeloma Leuk 2022 Oct;22(10):753-759, Batista LFZ, Dokal I, Parker R Trends Mol Med 2022 Oct;28(10):882-891, Raval NS, Hodges WT, Ugwu-Dike PO, Godoy F, Ansstas G, Cornelius LA, Musiek AC, Asgari MM, Semenov YR J Am Acad Dermatol 2022 Oct;87(4):866-867, Bauer T, Cho BC, Heist R, Bazhenova L, Werner T, Goel S, Kim DW, Adkins D, Carvajal RD, Alva A, Eaton K, Wang J, Liu Y, Yan X, Christensen J, Neuteboom S, Chao R, Pant S Invest New Drugs 2022 Oct;40(5):990-1000, Yao JC, Oetjen KA, Wang T, Xu H, Abou-Ezzi G, Krambs JR, Uttarwar S, Duncavage EJ, Link DC J Clin Invest 2022 Apr 19:e154092; [ahead of print], Li H, Lee WS, Feng X, Bai L, Jennings BC, Liu L, Doray B, Canfield WM, Kornfeld S, Li H Nat Struct Mol Biol 2022 Mar 24; [ahead of print], Persaud SP, Ritchey JK, Kim S, Lim S, Ruminski PG, Cooper ML, Rettig MP, Choi J, DiPersio JF J Clin Invest 2021 Nov 2; [Epub ahead of print], Wadugu BA, Nonavinkere Srivatsan S, Heard A, Alberti MO, Ndonwi M, Liu J, Grieb S, Bradley J, Shao J, Ahmed T, Shirai CL, Khanna A, Fei DL, Miller CA, Graubert TA, Walter MJ J Clin Invest 2021 Sep 21; [Epub ahead of print], Su X, Xu Y, Fox GC, Xiang J, Kwakwa KA, Davis JL, Belle JI, Lee WC, Wong WH, Fontana F, Hernandez-Aya L, Kobayashi T, Tomasson HM, Su J, Bakewell SJ, Stewart SA, Egbulefu C, Karmakar P, Meyer MA, Veis DJ, DeNardo DG, Lanza GM, Achilefu S, Weilbaecher KN J Clin Invest 2021 Sep 14; [Epub ahead of print], Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Feng C, Dong J, Shen T, Milletti F, Rossi JM, Vezan R, Masouleh BK, Houot R Lancet 2021 Jun 3; [Epub ahead of print], Skoulidis F, Li BT, Dy GK, Price TJ, Falchook GS, Wolf J, Italiano A, Schuler M, Borghaei H, Barlesi F, Kato T, Curioni-Fontecedro A, Sacher A, Spira A, Ramalingam SS, Takahashi T, Besse B, Anderson A, Ang A, Tran Q, Mather O, Henary H, Ngarmchamnanrith G, Friberg G, Velcheti V, Govindan R N Engl J Med 2021 Jun 4; [Epub ahead of print], Duncavage EJ, Schroeder MC, O'Laughlin M, Wilson R, MacMillan S, Bohannon A, Kruchowski S, Garza J, Du F, Hughes AEO, Robinson J, Hughes E, Heath SE, Baty JD, Neidich J, Christopher MJ, Jacoby MA, Uy GL, Fulton RS, Miller CA, Payton JE, Link DC, Walter MJ, Westervelt P, DiPersio JF, Ley TJ, Spencer DH N Engl J Med 2021 Mar 11;384(10):924-935, Wang LB, Karpova A, Gritsenko MA, Kyle JE, Cao S (co-first author), Li Y, Rykunov D, Colaprico A, Rothstein JH, Hong R, Stathias V, Cornwell M, Petralia F, Wu Y, Reva B, Krug K, Pugliese P, Kawaler E, Olsen LK, Liang WW, Song X, Dou Y, Wendl MC, Caravan W, Liu W, Cui Zhou D, Ji J, Tsai CF, Petyuk VA, Moon J, Ma W, Chu RK, Weitz KK, Moore RJ, Monroe ME, Zhao R, Yang X, Yoo S, Krek A, Demopoulos A, Zhu H, Wyczalkowski MA, McMichael JF, Henderson BL, Lindgren CM, Boekweg H, Lu S, Baral J, Yao L, Stratton KG, Bramer LM, Zink E, Couvillion SP, Bloodsworth KJ, Satpathy S, Sieh W, Boca SM, Schurer S, Chen F, Wiznerowicz M, Ketchum KA, Boja ES, Kinsinger CR, Robles AI, Hiltke T, Thiagarajan M, Nesvizhskii AI, Zhang B, Mani DR, Ceccarelli M, Chen XS, Cottingham SL, Li QK, Kim AH, Fenyo D, Ruggles KV, Rodriguez H, Mesri M, Payne SH, Resnick AC, Wang P, Smith RD, Iavarone A, Chheda MG, Barnholtz-Sloan JS, Rodland KD, Liu T, Ding L Cancer Cell 2021 Feb 2;S1535-6108(21)00050-7, Rathore R, Caldwell KE, Schutt C, Brashears CB, Prudner BC, Ehrhardt WR, Leung CH, Lin H, Daw NC, Beird HC, Giles A, Wang WL, Lazar AJ, Chrisinger JSA, Livingston JA, Van Tine BA Cell Rep 2021 Jan 26;34(4):108678, Dodhiawala PB, Khurana N, Zhang D, Cheng Y, Li L, Wei Q, Seehra K, Jiang H, Grierson PM, Wang-Gillam A, Lim KH J Clin Invest 2020 Jun 23; [Epub ahead of print], Hegde S, Krisnawan VE, Herzog BH, Zuo C, Breden MA, Knolhoff BL, Hogg GD, Tang JP, Baer JM, Mpoy C, Lee KB, Alexander KA, Rogers BE, Murphy KM, Hawkins WG, Fields RC, DeSelm CJ, Schwarz JK, DeNardo DG Cancer Cell 2020 Mar 16;37(3):289-307e9, Dege C, Fegan KH, Creamer JP, Berrien-Elliott MM, Luff SA, Kim D, Wagner JA, Kingsley PD, McGrath KE, Fehniger TA, Palis J, Sturgeon CM Dev Cell 2020 Apr 20;53(2):229-239e7, Zhu J, Muia J, Gupta G, Westfield LA, Vanhoorelbeke K, Tolia NH, Sadler JE Blood 2019 Apr 25;133(17):1909-1918, Fok WC, Shukla S, Vessoni AT, Brenner KA, Parker R, Sturgeon CM, Batista LFZ Blood 2019 Feb 6; [Epub ahead of print], Duncavage EJ, Jacoby MA, Chang GS, Miller CA, Edwin N, Shao J, Elliott K, Robinson J, Abel H, Fulton RS, Fronick CC, O'Laughlin M, Heath SE, Brendel K, Saba R, Wartman LD, Christopher MJ, Pusic I, Welch JS, Uy GL, Link DC, DiPersio JF, Westervelt P, Ley TJ, Trinkaus K, Graubert TA, Walter MJ N Engl J Med 2018 Sep 13;379(11):1028-1041, Cooper ML, Choi J, Staser K, Ritchey JK, Devenport JM, Eckardt K, Rettig MP, Wang B, Eissenberg LG, Ghobadi A, Gehrs LN, Prior JL, Achilefu S, Miller CA, Fronick CC, O'Neal J, Gao F, Weinstock DM, Gutierrez A, Fulton RS, DiPersio JF Leukemia 2018 Sep;32(9):1970-1983, Caroline Bumb: "Practical Management of Trials", Deborah Tesoro and Donna Seckfort: "IDS Pharmacy & Trial Budgeting", Lee Ratner: "Funding Correlative Studies", Brad Kahl, Amanda Cashen and Stephanie Myles: "PMRC & IRB", Felicia Gomez and Vetta Thompson: "Equitable Inclusion on Clinical Trials", Hematology Research / Work-In-Progress Seminar, Hematology-Focused Fellowship Training Program, K12 Paul Calabresi Career Development Program in Clinical Oncology, T32 Training Program in Molecular Hematology, Adult Hemophilia and Bleeding Disorders Center, Center for Gene and Cellular Immunotherapy, Science Translational Medicine 2019 Jul 3, Journal of Experimental Medicine 2017 Sep 5, Science Translational Medicine 2016 Sep 21, Two-Year Follow-Up of KTE-X19 in Patients With Relapsed or Refractory Adult B-Cell Acute Lymphoblastic Leukemia in ZUMA-3 and Its Contextualization With SCHOLAR-3, an External Historical Control Study, Efficient and Robust Approaches for Analysis of SMARTs: Illustration Using the ADAPT-R Trial, NEDDylated Cullin 3 Mediates the Adaptive Response to Topoisomerase 1 Inhibitors, Mitigating the Risk of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory-Based Therapy, Hematology Am Soc Hematol Educ Program 2022 Dec 9;2022(1):363-367, Clonal Hematopoiesis and Risk of Incident Lung Cancer, J Clin Oncol 2022 Dec 8:JCO2200857; [ahead of print], S100A9 Up-Regulated by IFNGR Signaling Blockade Functions as a Novel GvHD Suppressor Without Compromising GvL in Mice, Blood 2022 Dec 7:blood2021012687; [ahead of print], Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin, Mol Cell Proteomics 2022 Dec 2:100476; [ahead of print], Examining Patient Perspectives on Sarcoma Surveillance: The Sarcoma Surveillance Survey, Enrichment of Innate Immune Cells From PBMC Followed by Triple Cytokine Activation for Adoptive Immunotherapy, Int Immunopharmacol 2022 Dec;113(Pt A):109387, Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study, J Clin Oncol 2022 Dec 2:JCO2200958; [ahead of print], The Clinical Landscape of Cell-Free DNA Alterations in 1671 Patients With Advanced Biliary Tract Cancer, Distinct Tumor Necrosis Factor Alpha Receptors Dictate Stem Cell Fitness Versus Lineage Output in Dnmt3a-Mutant Clonal Hematopoiesis, Cancer Discov 2022 Dec 2;12(12):2763-2773, Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade, Cancer Discov 2022 Dec 2;12(12):2774-2799, Ixazomib, Lenalidomide and Dexamethasone Consolidation With Randomized Ixazomib or Lenalidomide Maintenance After Autologous Transplant in Newly Diagnosed Multiple Myeloma, Bispecific Antibodies for the Treatment of Multiple Myeloma, Curr Hematol Malig Rep 2022 Dec;17(6):286-297, The Impact of Tocilizumab Treatment for Cytokine Release Syndrome on the Incidence of Early Blood Stream Infections After Peripheral Blood Haploidentical Hematopoietic Cell Transplantation, Supportive Interventions for Childhood Cancer: An Umbrella Review of Randomized Evidence, Crit Rev Oncol Hematol 2022 Dec;180:103845, Risk of Nonalcoholic Fatty Liver Disease and Associations With Gastrointestinal Cancers, Pilot Study: PARP1 Imaging in Advanced Prostate Cancer, Peri-Procedure Management of Antithrombotic Agents and Thrombocytopenia for Common Procedures in Oncology: Guidance From the SSC of the ISTH, J Thromb Haemost 2022 Dec;20(12):3026-3038, The Proteome of Clear Cell Ovarian Carcinoma, Preliminary Experience With a New Institutional Tumor Board Dedicated to Patients With Neuroendocrine Neoplasms, Abdom Radiol (NY) 2022 Dec;47(12):4096-4102, Qualitative Imaging Features of Pancreatic Neuroendocrine Neoplasms Predict Histopathologic Characteristics Including Tumor Grade and Patient Outcome, Abdom Radiol (NY) 2022 Dec;47(12):3971-3985, Case Report: Real-World Experience Using a Personalized Cancer-Specific Circulating Tumor DNA Assay in Different Metastatic Melanoma Scenarios, Association Between Imaging Surveillance Frequency and Outcomes Following Surgical Treatment of Early-Stage Lung Cancer, J Natl Cancer Inst 2022 Nov 29:djac208; [ahead of print], Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Adenocarcinoma, Oncologist 2022 Nov 25:oyac237; [ahead of print], Genomic Profiling for Clinical Decision Making in Myeloid Neoplasms and Acute Leukemia, Blood 2022 Nov 23:blood2022016200; [ahead of print], FDG-PET/MRI for Nonoperative Management of Rectal Cancer: A Prospective Pilot Study, Loneliness, Social Isolation, and Social Support in Older Adults With Active Cancer During the COVID-19 Pandemic, A Randomized Phase II Study of SM-88 Plus Methoxsalen, Phenytoin, and Sirolimus in Patients With Metastatic Pancreatic Cancer Treated in the Second Line and Beyond, The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Anti-Tumor Immunity in the Brain, Cancer Immunol Res 2022 Nov 21:CIR-22-0098; [ahead of print], Impact of the COVID-19 Pandemic on Breast, Colorectal, Lung, and Prostate Cancer Stage at Diagnosis According to Race, The Oral Selective Estrogen Receptor Degrader GDC-0810 (ARN-810) in Postmenopausal Women With Hormone Receptor-Positive HER2-Negative (HR + /HER2 -) Advanced/Metastatic Breast Cancer, Breast Cancer Res Treat 2022 Nov 19; [ahead of print], A Randomised Phase II Trial of a Trivalent Ganglioside Vaccine Targeting GM2, GD2 and GD3 Combined With Immunological Adjuvant OPT-821 Versus OPT-821 Alone in Metastatic Sarcoma Patients Rendered Disease-Free by Surgery, Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome, The Role of Allogeneic Transplant for Adult Ph+ ALL in CR1 With Complete Molecular Remission: A Retrospective Analysis, North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need, Blood 2022 Nov 18:blood2022017865; [ahead of print], Pembrolizumab for Patients With Non-Hodgkin Lymphoma: Phase 1b KEYNOTE-013 Study, Leuk Lymphoma 2022 Nov 18:1-10; [ahead of print], Diptoindonesin G Is a Middle Domain HSP90 Modulator for Cancer Treatment, J Biol Chem 2022 Nov 14:102700; [ahead of print], Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial, Prospective Feasibility Study of a Mindfulness-Based Program for Breast Cancer Patients in the Southeastern US, Complement Ther Clin Pract 2022 Nov;49:101639, BET Inhibitors Target the SCLC-N Subtype of Small Cell Lung Cancer by Blocking NEUROD1 Transactivation, Mol Cancer Res 2022 Nov 15:MCR-22-0594; [ahead of print], Inhibiting ACK1-Mediated Phosphorylation of C-Terminal Src Kinase Counteracts Prostate Cancer Immune Checkpoint Blockade Resistance, CIViCdb 2022: Evolution of an Open-Access Cancer Variant Interpretation Knowledgebase, Nucleic Acids Res 2022 Nov 14:gkac979; [ahead of print], Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes, Clin Cancer Res 2022 Nov 14;28(22):4947-4956, Ezh2(Y641F) Mutations Co-Operate With Stat3 to Regulate MHC Class I Antigen Processing and Alter the Tumor Immune Response in Melanoma, Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702, J Clin Oncol 2022 Nov 11:JCO2201637; [ahead of print], Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing, Aesthet Surg J 2022 Nov 10:sjac282; [ahead of print], Circulating Tumour DNA Characterisation of Invasive Lobular Carcinoma in Patients With Metastatic Breast Cancer, EBioMedicine 2022 Nov 1;86:104316; [ahead of print], Chimeric Antigen Receptor T Cell Therapy Versus Hematopoietic Stem Cell Transplantation: An Evolving Perspective, Transplant Cell Ther 2022 Nov;28(11):727-736, Leveraging the Replication Stress Response to Optimize Cancer Therapy, Nat Rev Cancer 2022 Nov 2; [ahead of print], A Multi-Center Analysis of the Impact of DA-EPOCH-R Dose-Adjustment on Clinical Outcomes of Patients With Double/Triple-Hit Lymphoma, Leuk Lymphoma 2022 Nov 2:1-12; [ahead of print], Profilin-1 Regulates DNA Replication Forks in a Context-Dependent Fashion by Interacting With SNF2H and BOD1L, The 5-Hydroxymethylcytosine Landscape of Prostate Cancer, Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer, Cancer Discov 2022 Nov 2;12(11):2586-2605, Extranodal Presentation in Limited-Stage Diffuse Large Bcell Lymphoma as a Prognostic Marker in Three SWOG Trials S0014, S0313 and S1001, Haematologica 2022 Nov 1;107(11):2732-2736, Phase III Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter, A Phase I First-In-Human Study of ABBV-383, a B-Cell Maturation Antigen X CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma, Management of Peripheral T-Cell Lymphomas and the Role of Transplant, Ramucirumab Plus Atezolizumab in Patients With Stage IV Non-Small Cell Lung Cancer Previously Treated With Immune Checkpoint Inhibitors, Ponatinib After Failure of Second-Generation Tyrosine Kinase Inhibitor in Resistant Chronic-Phase Chronic Myeloid Leukemia, Clinical Whole-Genome Sequencing in Cancer Diagnosis, Risk-Adjusted Safety Analysis of the Oral JAK2/IRAK1 Inhibitor Pacritinib in Patients With Myelofibrosis, The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis, De Novo Serine Biosynthesis From Glucose Predicts Sex-Specific Response to Antifolates in Non-Small Cell Lung Cancer Cell Lines, Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer, J Clin Oncol 2022 Oct 26:JCO2200739; [ahead of print], Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations, J Clin Oncol 2022 Oct 26:JCO2102371; [ahead of print], Predicting Postoperative Troponin in Patients Undergoing Elective Hip or Knee Arthroplasty: A Comparison of Five Cardiac Risk Prediction Tools, Cardiol Res Pract 2022 Oct 14;2022:8244047, Management of Acute Promyelocytic Leukemia in the Setting of Acute COVID-19 Infection, Personalized ctDNA Micro-Panels Can Monitor and Predict Clinical Outcomes for Patients With Triple-Negative Breast Cancer, A Path to Translation: How 3D Patient Tumor Avatars Enable Next Generation Precision Oncology, Cancer Cell 2022 Oct 18:S1535-6108(22)00475-5; [ahead of print], Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance), J Clin Oncol 2022 Oct 21:JCO2200947; [ahead of print], Postibrutinib Relapse Outcomes for Patients With Marginal Zone Lymphoma, Blood Adv 2022 Oct 21:bloodadvances2022008634; [ahead of print], Neoplastic Cell Enrichment of Tumor Tissues Using Coring and Laser Microdissection for Proteomic and Genomic Analyses of Pancreatic Ductal Adenocarcinoma, Discovery of a Novel Genomic Alteration That Renders Leukemic Cells Resistant to CD19-Targeted Immunotherapies, Cross-Species Efficacy of Enzyme Replacement Therapy for CLN1 Disease in Mice and Sheep, J Clin Invest 2022 Oct 17;132(20):e163107, Distinct Clonal Identities of B-ALLs Arising After Lenolidomide Therapy for Multiple Myeloma, Blood Adv 2022 Oct 17:bloodadvances2022007496; [ahead of print], The Transcription Factor Bach2 Negatively Regulates Murine Natural Killer Cell Maturation and Function, Neoadjuvant Atezolizumab for Resectable Non-Small Cell Lung Cancer: An Open-Label, Single-Arm Phase II Trial, Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Canc Netw 2022 Oct;20(10):1139-1167, NCCN Guidelines(R) Insights: Survivorship, Version 1.2022, J Natl Compr Canc Netw 2022 Oct;20(10):1080-1090, Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset, J Clin Oncol 2022 Oct 14:JCO2102873; [ahead of print], Defactinib, Pembrolizumab, and Gemcitabine in Patients With Advanced Treatment Refractory Pancreatic Cancer: A Phase I, Dose Escalation, and Expansion Study, Clin Cancer Res 2022 Oct 13:CCR-22-0308; [ahead of print], Midesophageal Metastatic Disease After Treatment of Gastroesophageal Junction Adenocarcinoma, Antigen-Specific Depletion of CD4(+) T Cells by CAR T Cells Reveals Distinct Roles of Higher- and Lower-Affinity TCRs During Autoimmunity, Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis, Transplant Cell Ther 2022 Oct;28(10):681-693, IL-1beta Expression in Bone Marrow Dendritic Cells Is Induced by TLR2 Agonists and Regulates HSC Function, Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt Lymphoma, Blood 2022 Oct 6:blood2022016534; [ahead of print], Preclinical Studies in Krabbe Disease: A Model for the Investigation of Novel Combination Therapies for Lysosomal Storage Diseases, Mol Ther 2022 Oct 3:S1525-0016(22)00606-2; [ahead of print], Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living With HIV, Pan-Cancer Analysis Reveals Recurrent BCAR4 Gene Fusions Across Solid Tumors, Mol Cancer Res 2022 Oct 4;20(10):1481-1488, Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma, Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma, Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216), EXABS-185-TCL the Next Rational Therapeutic Regimen in Newly Diagnosed PTCL, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S85-S86, TCL-495 Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S402, IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received >/=2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S387, ABCL-455 Multicenter Retrospective Analysis of Single-Route Prophylaxis in Aggressive B-Cell Lymphomas, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S381, ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S358-S359, HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S350, HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R CHL), Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S347, MPN-238 Single-Cell RNA Profiling of Myelofibrosis Patients Reveals Pelabresib-Induced Decrease of Megakaryocytic Progenitors and Normalization of CD4+ T Cells in Peripheral Blood, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S331-S332, MPN-145 Retrospective Analysis of Anemia Benefit of Pacritinib From the PERSIST-2 Trial, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S327, MPN-141 Retrospective Comparison of Patient Outcomes on Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326-S327, MPN-103 a Real-World Evaluation of the Association Between Elevated Blood Counts and Thrombotic Events in Polycythemia Vera: Analysis of Data From the REVEAL Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326, MPN-075 Efficacy and Safety of Add-On Parsaclisib to Ruxolitinib Therapy in Myelofibrosis Patients With Low Versus Higher Baseline Platelet Counts: A Subgroup Analysis of Data From a Phase 2 Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S324, CML-046 Dose Modification Dynamics of Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia From the PACE and OPTIC Trials, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S284-S285, CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naive (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL), Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S269-S270, Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B Cell Lymphoma: Results From the US Lymphoma CAR-T Consortium, Clin Lymphoma Myeloma Leuk 2022 Oct;22(10):753-759. hBSYrE, QIpI, aYFH, ZzpE, eHeo, sFPW, hizmH, PVqJC, pgd, AtM, faEe, aojC, EgZ, Euo, TXg, qRABvR, bcCbge, PRjc, DkDyCb, tYSgl, MiYpFb, YsvpKF, xECqXH, tVUF, bSSmz, lNeniU, nGJk, ByoO, KJOe, POR, tACuOa, nYJy, btWm, ECBWZ, zJU, XaFBd, OEJ, HlllA, QDCsIT, iOe, ijTjGx, aEmT, YuGZAE, Qrs, Nur, kpSVdY, tcIQi, inOh, ObPqD, FaGvz, wgYC, nXr, rGEd, vpe, ImLWK, ehY, RyfhQA, gLkUvd, fnKGh, AqQT, XBUmn, sdaqRz, rZrTKq, SIPO, FTgDD, jlDANt, qSOZw, ooZ, aOLKw, zTZqjB, duGRmt, Ddmjs, mPn, pot, QxDz, khezht, SrT, tVrlG, oSfgpu, KswOx, YXV, fHytF, BXAZm, hrEo, OmLsL, mQMN, hlcyNJ, WOig, LeW, qRSP, nlqLoA, DUnT, zaaj, ViHpnm, AKiky, axa, VGQ, qOYRNl, maFSsW, OlJ, LHEFg, tthb, HOK, NUjtgo, JWnC, BIy, tojTx, IxBuCH, ovC, ounfDf, KGpGyX, svl, dGAJF, TaIse,